Update on the Latest Strategies to Diagnose and Treat Neurotrophic Keratitis: An Evening With the DAO (Archived CME Webcast)

This educational activity has expired. You will not be able to claim credit for this activity.

Activity Description and Purpose

Neurotrophic keratitis is characterized by disrupted tearing and progressive corneal damage that does not readily heal. Until very recently, a lack of effective treatment to reinnervate and heal eyes affected by NK served to further hamper efforts toward timely diagnosis. Now that an effective treatment is available, ophthalmologists need to identify patients who might benefit from treatment before the disease progresses to the point of corneal perforation and subsequent loss of visual acuity. This webcast captures the proceedings from a CME live internet presentation hosted by the Dallas Ophthalmology Society (DAO) on December 3, 2020. The desired results of this educational activity are for ophthalmologists to have a better understanding of the pathophysiology of NK as well as current best practices for screening, diagnosis, and treatment.

This continuing medical education activity is provided by MedEdicus LLC.



This continuing medical education activity is supported through an educational grant from Dompé US, Inc.

Target Audience

This educational activity is intended for ophthalmologists.

Learning Objectives

After completing this activity, participants will be better able to:

  • Describe the pathophysiology of neurotrophic keratitis
  • Integrate evaluation of corneal sensitivity into assessment of ocular surface disease 
  • Review evidence of corneal healing and reinnervation in patients treated with recombinant human nerve growth factor
  • Identify treatment strategies for patients diagnosed with any stage of neurotrophic keratitis
Course summary
Course opens: 
Course expires: 


imageStephen C. Pflugfelder, MD
Professor of Ophthalmology
James and Margaret Elkins Chair
Baylor College of Medicine
Houston, Texas
imageKarolinne M. Rocha, MD, PhD
Director, Cornea and Refractive Surgery Division
Medical University of South Carolina
Storm Eye Institute
Mt Pleasant, South Carolina

Disclosure Policy

MedEdicus requires that anyone who is in a position to control the content of this educational activity disclose all relevant financial relationships with any commercial interest. Financial relationship information is collected and resolved prior to the educational activity.


Stephen C. Pflugfelder, MD, is a consultant for Dompé US, Inc, Kala Pharmaceuticals, KOWA Pharmaceuticals America, Inc, Novartis Pharmaceuticals Corporation, and Senju Pharmaceutical Co, Ltd; and is a contracted researcher for Dompé US, Inc, and Novartis Pharmaceuticals Corporation.

Karolinne M. Rocha, MD, PhD, is a consultant for Dompé US, Inc.

Peer Reviewer

This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.

Planners and Managers

MedEdicus planners and managers have no relevant commercial relationships to disclose.  

Accreditation Statement

imageMedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

MedEdicus LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Commercial Support

This continuing medical education activity is supported through an educational grant from Dompé US, Inc.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.


The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC or Dompé US, Inc.

This CME activity is copyrighted to MedEdicus LLC ©2021. All rights reserved. 238

Please login or register to take this course.

This educational activity has expired. You will not be able to claim credit for this activity.